Therapy of hypertension in patients with type 2 diabetes mellitus

被引：1
作者：
Hess, K. [1 ]
机构：
[1] Rhein Westfal TH Aachen, Univ Klinikum Aachen, Med Klin Kardiol Pneumol Angiol & Internist Inten, D-52074 Aachen, Germany
来源：
DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT | 2012年 / 137卷 / 48期
关键词：
Type; 2; diabetes; Hypertension; metabolic syndrome; RENIN-ANGIOTENSIN SYSTEM; CALCIUM-CHANNEL BLOCKER; BLOOD-PRESSURE CONTROL; CARDIOVASCULAR MORBIDITY; RANDOMIZED-TRIAL; METABOLIC SYNDROME; DOUBLE-BLIND; END-POINT; RISK; OUTCOMES;
D O I：
10.1055/s-0032-1327287
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：2489 / 2492
页数：4
相关论文
共 31 条
[1]  
ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group, 2002, JAMA, V288, P2981
[2]   Cardiovascular disease in patients with diabetic nephropathy [J].
Aso, Yoshimasa .
CURRENT MOLECULAR MEDICINE, 2008, 8 (06) :533-543
[3]   Renal outcomes with different fixed-dose combination therapies in patients with hypertension at high risk for cardiovascular events (ACCOMPLISH): a prespecified secondary analysis of a randomised controlled trial [J].
Bakris, George L. ;
Sarafidis, Pantelis A. ;
Weir, Matthew R. ;
Dahlof, Bjorn ;
Pitt, Bertram ;
Jamerson, Kenneth ;
Velazquez, Eric J. ;
Staikos-Byrne, Linda ;
Kelly, Roxzana Y. ;
Shi, Victor ;
Chiang, Yann-Tong ;
Weber, Michael A. .
LANCET, 2010, 375 (9721) :1173-1181
[4]   Diabetes and atherosclerosis - Epidemiology, pathophysiology, and management [J].
Beckman, JA ;
Creager, MA ;
Libby, P .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 287 (19) :2570-2581
[5]   Morbidity and mortality in patients randomised to double-blind treatment with a long-acting calcium-channel blocker or diuretic in the International Nifedipine GITS study: Intervention as a Goal in Hypertension Treatment (INSIGHT) [J].
Brown, MJ ;
Palmer, CR ;
Castaigne, A ;
de Leeuw, PW ;
Mancia, G ;
Rosenthal, T ;
Ruilope, LM .
LANCET, 2000, 356 (9227) :366-372
[6]   Effects of Intensive Blood-Pressure Control in Type 2 Diabetes Mellitus [J].
Cushman, William C. ;
Evans, Gregory W. ;
Byington, Robert P. ;
Goff, David C., Jr. ;
Grimm, Richard H., Jr. ;
Cutler, Jeffrey A. ;
Simons-Morton, Denise G. ;
Basile, Jan N. ;
Corson, Marshall A. ;
Probstfield, Jeffrey L. ;
Katz, Lois ;
Peterson, Kevin A. ;
Friedewald, William T. ;
Buse, John B. ;
Bigger, J. Thomas ;
Gerstein, Hertzel C. ;
Ismail-Beigi, Faramarz .
NEW ENGLAND JOURNAL OF MEDICINE, 2010, 362 (17) :1575-1585
[7]   The effect of nisoldipine as compared with enalapril on cardiovascular outcomes in patients with non-insulin-dependent diabetes and hypertension [J].
Estacio, RO ;
Jeffers, BW ;
Hiatt, WR ;
Biggerstaff, SL ;
Gifford, N ;
Schrier, RW .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 338 (10) :645-652
[8]   Olmesartan for the Delay or Prevention of Microalbuminuria in Type 2 Diabetes [J].
Haller, Hermann ;
Ito, Sadayoshi ;
Izzo, Joseph L., Jr. ;
Januszewicz, Andrzej ;
Katayama, Shigehiro ;
Menne, Jan ;
Mimran, Albert ;
Rabelink, Ton J. ;
Ritz, Eberhard ;
Ruilope, Luis M. ;
Rump, Lars C. ;
Viberti, Giancarlo .
NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (10) :907-917
[9]   Randomised trial of effects of calcium antagonists compared with diuretics and β-blockers on cardiovascular morbidity and mortality in hypertension:: the Nordic Diltiazem (NORDIL) study [J].
Hansson, L ;
Hedner, T ;
Lund-Johansen, P ;
Kjeldsen, SE ;
Lindholm, LH ;
Syvertsen, JO ;
Lanke, J ;
de Faire, U ;
Dahlöf, B ;
Karlberg, BE .
LANCET, 2000, 356 (9227) :359-365
[10]  
HESS K, 2009, MED WELT, V60, P371
1234